Breast cancer drug offers protection against obesity-related metabolic disorders


Posted in: Medical Science News | Medical Research News | Women’s Health News | Pharmaceutical News

Tags: Breast Cancer, Cancer, Diabetes, Diet, Estrogen, Evolution, Fatty Liver, Gene, Gene Expression, Genes, in vivo, Insulin, Insulin Resistance, Liver, Liver Disease, Magnetic Resonance Imaging, Metabolic Disorders, Obesity, Pathology, Placebo, Steatosis, Tamoxifen, Type 2 Diabetes